Filter News
Area of Research
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (4)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (1)
- Advanced Reactors (3)
- Artificial Intelligence (1)
- Big Data (1)
- Composites (1)
- Computer Science (2)
- Cybersecurity (1)
- Energy Storage (1)
- Environment (2)
- Fusion (1)
- Grid (1)
- Isotopes (1)
- Machine Learning (1)
- Materials Science (1)
- Microscopy (1)
- Molten Salt (2)
- Nanotechnology (1)
- Neutron Science (18)
- Nuclear Energy (9)
- Physics (3)
- Quantum Science (1)
- Space Exploration (2)
- Transportation (1)
Media Contacts
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
Thought leaders from across the maritime community came together at Oak Ridge National Laboratory to explore the emerging new energy landscape for the maritime transportation system during the Ninth Annual Maritime Risk Symposium.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.